Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-02
DOI
10.3389/fimmu.2021.732135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Generating natural killer cells for adoptive transfer: expanding horizons
- (2021) Soumyadipta Kundu et al. CYTOTHERAPY
- A robust platform for expansion and genome editing of primary human natural killer cells
- (2021) Rih-Sheng Huang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Engineering NK Cells for CAR Therapy—Recent Advances in Gene Transfer Methodology
- (2021) Paula Schmidt et al. Frontiers in Immunology
- Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion
- (2021) David S.J. Allan et al. Molecular Therapy-Methods & Clinical Development
- Delivery technologies to engineer natural killer cells for cancer immunotherapy
- (2021) Rakan El-Mayta et al. CANCER GENE THERAPY
- Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
- (2021) Ying Gong et al. Journal of Hematology & Oncology
- Nonviral genome engineering of natural killer cells
- (2021) Gabrielle M. Robbins et al. Stem Cell Research & Therapy
- Non‐clinical efficacy, safety, and stable clinical cell processing of iPSC‐derived anti‐GPC3 CAR‐expressing NK/ILC cells
- (2020) Tatsuki Ueda et al. CANCER SCIENCE
- Tissue Determinants of Human NK Cell Development, Function, and Residence
- (2020) Pranay Dogra et al. CELL
- Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy
- (2020) Cassie K. Chou et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
- (2020) S. Depil et al. NATURE REVIEWS DRUG DISCOVERY
- NK cells for cancer immunotherapy
- (2020) Noriko Shimasaki et al. NATURE REVIEWS DRUG DISCOVERY
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials
- (2020) Khalil Choucair et al. CANCER GENE THERAPY
- An off the shelf, GMP compliant,fully closed and semi-automated large-scale production system for allogeneic NK cells
- (2020) J. Veluchamy CYTOTHERAPY
- Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer
- (2020) Amy J. Petty et al. Cancers
- Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK Cells with Enhanced Antitumor Activity
- (2020) Pranav Oberoi et al. Cells
- Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?
- (2020) Uri Greenbaum et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Natural killer cells in cancer biology and therapy
- (2020) Song-Yang Wu et al. Molecular Cancer
- Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
- (2020) Keerthana Shankar et al. Stem Cell Research & Therapy
- Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation
- (2020) Lixia Sheng et al. Frontiers in Immunology
- Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells
- (2020) Michael A. Morgan et al. Frontiers in Immunology
- Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor
- (2020) Ying Gong et al. Molecular Therapy-Methods & Clinical Development
- Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy
- (2020) Alejandra Gutierrez-Guerrero et al. Viruses-Basel
- Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells
- (2020) Christoph Mark et al. Nature Communications
- TIGIT in cancer immunotherapy
- (2020) Joe-Marc Chauvin et al. Journal for ImmunoTherapy of Cancer
- Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
- (2019) Lin Xiao et al. MOLECULAR THERAPY
- Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing
- (2019) Tiziano Ingegnere et al. Frontiers in Immunology
- Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
- (2019) Kyle B. Lupo et al. Cancers
- Correction to: IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
- (2019) Yeon Ho Choi et al. Journal for ImmunoTherapy of Cancer
- Mass Production of Highly Active NK Cells for Cancer Immunotherapy in a GMP Conform Perfusion Bioreactor
- (2019) Katharina Bröker et al. Frontiers in Bioengineering and Biotechnology
- A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy
- (2019) Emily J. Pomeroy et al. MOLECULAR THERAPY
- Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
- (2019) Evelyn O. Ojo et al. Scientific Reports
- Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
- (2019) L. Herrera et al. Scientific Reports
- The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation
- (2019) Annekathrin Heinze et al. Frontiers in Immunology
- Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped Lentivector
- (2019) Aurelien B. L. Colamartino et al. Frontiers in Immunology
- Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell
- (2018) Chu Lin et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Mechanistic insights into cancer immunity and immunotherapy
- (2018) Weiping Zou Cellular & Molecular Immunology
- Activated pancreatic stellate cells inhibit NK cell function in the human pancreatic cancer microenvironment
- (2018) Qiang Huang et al. Cellular & Molecular Immunology
- A semi-automated, high-purity process for natural killer (NK) cell manufacturing in a rocking bioreactor
- (2018) Y.S. Gratch et al. CYTOTHERAPY
- Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution
- (2018) Shelly M. Williams et al. TRANSFUSION
- Rapid expansion in the WAVE bioreactor of clinical scale cells for tumor immunotherapy
- (2018) Yiming Meng et al. Human Vaccines & Immunotherapeutics
- Genome-wide analyses and functional profiling of human NK cell lines
- (2018) Justin T. Gunesch et al. MOLECULAR IMMUNOLOGY
- Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
- (2018) Sandro Matosevic Journal of Immunology Research
- Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy
- (2018) Bokyung Min et al. Immune Network
- Warm up, cool down, and tearing apart in NK cell memory
- (2018) Lawrence Shih-Hsin Wu et al. Cellular & Molecular Immunology
- A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy
- (2017) Brent A. Williams et al. Oncotarget
- Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody
- (2017) Ying Chen et al. Oncotarget
- Tools for translation: non-viral materials for therapeutic mRNA delivery
- (2017) Khalid A. Hajj et al. Nature Reviews Materials
- Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment
- (2016) Jeremiah L. Oyer et al. CYTOTHERAPY
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
- (2016) Y. Yang et al. Cancer Immunology Research
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma
- (2016) Markus Granzin et al. OncoImmunology
- Practical NK cell phenotyping and variability in healthy adults
- (2015) Laura S. Angelo et al. IMMUNOLOGIC RESEARCH
- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
- (2015) Susann Szmania et al. JOURNAL OF IMMUNOTHERAPY
- Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors
- (2015) Julia D. Suerth et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
- (2015) David L. Hermanson et al. Frontiers in Immunology
- Advances in clinical NK cell studies: Donor selection, manufacturing and quality control
- (2015) U. Koehl et al. OncoImmunology
- Improving DNA Vaccine Performance Through Vector Design
- (2014) James Williams CURRENT GENE THERAPY
- FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32)
- (2014) Nupur Bhatnagar et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons
- (2014) Elizabeth M. Hartfield et al. PLoS One
- The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells
- (2014) Cristina Cerboni et al. Frontiers in Immunology
- Ex Vivo Expansion of Highly Cytotoxic Human NK Cells by Cocultivation with Irradiated Tumor Cells for Adoptive Immunotherapy
- (2013) S. A. Lim et al. CANCER RESEARCH
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers
- (2013) Eun-Kyung Kim et al. CYTOTHERAPY
- Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
- (2013) Nina Shah et al. PLoS One
- Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
- (2013) David A. Knorr et al. Stem Cells Translational Medicine
- Cytokine activation induces human memory-like NK cells
- (2012) R. Romee et al. BLOOD
- Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
- (2012) Natalia Lapteva et al. CYTOTHERAPY
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
- (2010) S. Lopez-Verges et al. BLOOD
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Human Pluripotent Stem Cells Produce Natural Killer Cells That Mediate Anti-HIV-1 Activity by Utilizing Diverse Cellular Mechanisms
- (2010) Z. Ni et al. JOURNAL OF VIROLOGY
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity
- (2009) P. S. Woll et al. BLOOD
- Generation of donor natural killer cells from CD34+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study
- (2009) S R Yoon et al. BONE MARROW TRANSPLANTATION
- The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells
- (2009) Michael R. Verneris et al. BRITISH JOURNAL OF HAEMATOLOGY
- Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method
- (2009) L Li et al. CANCER GENE THERAPY
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
- (2009) Maria Berg et al. CYTOTHERAPY
- Cytokine-induced memory-like natural killer cells
- (2009) Megan A. Cooper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Interleukin-21 activates human natural killer cells and modulates their surface receptor expression
- (2007) Kresten Skak et al. IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now